A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and ...

MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...

Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol ...